Presynaptic dopamine terminal (DA terminal)

Presynaptic dopamine terminals are the specialized axonal endings of dopaminergic neurons, primarily located in the striatum, where the synthesis, storage, release, and reuptake of dopamine occur (StatPearls, NBK535451). These terminals are critical for maintaining dopaminergic tone and regulating motor control, reward, and executive function. In neurodegenerative conditions like Parkinson's disease, the progressive loss of these terminals is a hallmark feature, leading to motor deficits (NINDS, Parkinson's Disease Information Page). Pharmacological intervention at these sites often involves targeting the dopamine transporter (DAT) to inhibit reuptake or the vesicular monoamine transporter 2 (VMAT2) to modulate storage (UniProt, P23975). Additionally, imaging these terminals using radioligands like [123I]ioflupane serves as a vital diagnostic tool for assessing the integrity of the nigrostriatal pathway (PubMed, PMID: 11733018).

Other names

Dopaminergic nerve terminalDopaminergic boutonPresynaptic dopaminergic siteDopaminergic axon terminal

Drugs targeting the presynaptic dopamine terminal function by modulating the lifecycle of dopamine. This includes inhibiting the dopamine transporter (DAT) to increase synaptic dopamine levels, inhibiting the vesicular monoamine transporter 2 (VMAT2) to deplete vesicular stores, or providing metabolic precursors like Levodopa to bypass rate-limiting synthesis steps (StatPearls, NBK535451; PubChem, CID 9859096).